Bio News
South Korean researchers have shown for the first time in a 3D model that the order in which immune cells are introduced determines glioblastoma treatment outcomes. When NK cells were introduced first, tumors were suppressed through IL12A; when microglia were introduced first, tumors grew through STAT3 signaling. Combining a STAT3 inhibitor also increased NK-cell infiltration, an effect that could be used to develop personalized treatment platforms.
BIOBOOK TEAM
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
